Gene signatures predict biochemical recurrence‐free survival in primary prostate cancer patients after radical therapy

BACKGROUND: This study evaluated the predictive value of gene signatures for biochemical recurrence (BCR) in primary prostate cancer (PCa) patients. METHODS: Clinical features and gene expression profiles of PCa patients were attained from Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (T...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Qiang, Liu, Zhenyu, Chen, Chi, Gao, Han, Zhu, Yongbei, Wang, Liusu, Pan, Meiqing, Liu, Jiangang, Yang, Xin, Tian, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Bioinformatics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446568/
https://www.ncbi.nlm.nih.gov/pubmed/34453418
http://dx.doi.org/10.1002/cam4.4092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446568/
https://www.ncbi.nlm.nih.gov/pubmed/34453418
http://dx.doi.org/10.1002/cam4.4092

Ejemplares similares